Form 4 for DH Definitive Healthcare Corp.
Accepted 2025-12-23 00:00:00 ET · period of report 2025-12-22 · accession 0001193125-25-330842 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-23 | 2025-12-22 | DH | Graboske Benjamin | EVP, Chief Data Off | F - Tax | $2.53 | -341.4K | 676.9K | -34% | -$863.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-12-22 | F | D | 341,417 | $2.53 | 676,913 | D | — | — | (F2) Represents RSUs granted under the Definitive Healthcare Corp. 2023 Inducement Plan. In December 2025, the Definitive Healthcare Corp. Human Capital Management and Compensation Committee and Board of Directors approved the acceleration of the unvested shares underlying this grant, resulting in the award becoming 100% vested as of December 22, 2025. |